pro health bpc 157 ProHealth Longevity BPC‑157 Claims Evaluated: Most Effective BPC157 Peptide Brand on the Market (2026) ProHealth Longevity

The argument that arginate salt formulation constitutes a distinct compound outside the FDA's BPC-157 Category 2 ruling has not been validated by any FDA guidance

Total Blend Dose Syringe Units (U-100) Volume (mL) 1 mg 2.5 units 0.025 mL 2 mg 5 units 0.05 mL 3 mg 7.5 units 0.075 mL 4 mg 10 units 0.1 mL 5 mg 12.5 units 0.125 mL These conversions assume a U-100 insulin syringe , where 1mL equals 100 units

At 3mg, approximately 33 doses

299302, Placenta. Cleveland Clinic , my.clevelandclinic.org/health/body/22337-placenta

And the third included those without enough supporting information for the FDA to make an informed decision and therefore wouldnt be used for compounding

once opened, follow supplier beyond-use guidance